Discontinued — last reported Q3 '25

Current Assets

Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)

Labcorp Holdings Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) decreased by 11.0% to $532.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 65.0%, from $1.52B to $532.30M. Over 4 years (FY 2021 to FY 2025), Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) shows a downward trend with a -22.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2021
Last reportedQ3 2025

How to read this metric

An increase suggests improved liquidity and capacity for investment or debt repayment, while a decrease may indicate aggressive capital allocation or operational cash burn.

Detailed definition

This represents the total liquidity available to the company, including cash, cash equivalents, and restricted cash bala...

Peer comparison

Consumer staples companies typically maintain moderate cash buffers to manage working capital and dividend obligations.

Metric ID: cash_and_equivalents_total_inclusive

Historical Data

15 periods
 Q4 '21Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$1.47B$304.90M$430.00M$294.80M$1.93B$727.90M$536.80M$99.30M$265.10M$1.52B$1.52B$369.40M$647.30M$598.10M$532.30M
QoQ Change-79.3%+41.0%-31.4%+554.9%-62.3%-26.3%-81.5%+167.0%+472.4%+0.1%-75.7%+75.2%-7.6%-11.0%
YoY Change-70.8%+138.7%+24.8%-66.3%-86.3%+108.4%+182.9%+272.0%+144.2%-60.6%-65.0%
Range$99.30M$1.93B
CAGR-25.2%
Avg YoY Growth+47.5%
Median YoY Growth+24.8%
Current Streak2 quarters decline

Frequently Asked Questions

What is Labcorp Holdings's total cash, cash equivalents, and restricted cash (inclusive)?
Labcorp Holdings (LH) reported total cash, cash equivalents, and restricted cash (inclusive) of $532.30M in Q4 2025.
How has Labcorp Holdings's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
Labcorp Holdings's total cash, cash equivalents, and restricted cash (inclusive) decreased by 65.0% year-over-year, from $1.52B to $532.30M.
What is the long-term trend for Labcorp Holdings's total cash, cash equivalents, and restricted cash (inclusive)?
Over 4 years (2021 to 2025), Labcorp Holdings's total cash, cash equivalents, and restricted cash (inclusive) has grown at a -22.5% compound annual growth rate (CAGR), from $1.47B to $532.30M.
What does total cash, cash equivalents, and restricted cash (inclusive) mean?
The total amount of cash and highly liquid assets the company holds.